Oxford Immunotec (OXFD) Tops Q1 EPS by 5c, Beats on Revenues

Oxford Immunotec (NASDAQ: OXFD) reported Q1 EPS of ($0.40), $0.05 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $21.4 million versus the consensus estimate of $20.96 million.

GUIDANCE:

Oxford Immunotec sees FY2018 revenue of $112-115 million.

For earnings history and earnings-related data on Oxford Immunotec (OXFD) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c